pharma · Opioid Use Disorder · Opioid Dependence
Indivior Pty
Indivior Pty Ltd
Indivior is a pharma organization headquartered in Richmond, USA. Primary therapeutic focus areas include Opioid Use Disorder, Opioid Dependence, Schizophrenia, Opioid Dependency, Opiate Dependence. NovaPharmaNews links
., Richmond, VA, US HQ
967 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- ., Richmond, VA, US
- Employees
- 967
- Programs
- 39
- Drugs
- 19
- Patents
- 34
INDV-6001
Phase 2 · small molecule · Moderate to Severe Opioid Use Disorder
INDV-6001 for Moderate to Severe Opioid Use Disorder is a Phase 2 program (small_molecule) at Indivior Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code INDV-6001-201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Indivior Pty Ltd
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Moderate to Severe Opioid Use Disorder
- Status
- completed
- Trials
- 1